Results 61 to 70 of about 1,181 (167)
Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion. [PDF]
J Cancer Res Clin Oncol, 2023 Bartol A +5 more
europepmc +1 more source
, 1970 Voćni jogurt je relativno nov proizvod ne samo u našim mljekarama, već i u inostranim. Kombiniranjem dva diferentna proizvoda kao što su voće odnosno voćne prerađevine s mlijekom odnosno jogurtom stvoren je jedan nov proizvod, koji sudeći po prodoru na ...
Đorđe Zonji
core +1 more source
Evidence-based decision making in healthcare in Central Eastern Europe [PDF]
, 2014 Baltezarević, Dragana +4 more
core +1 more source
Pharmaceutical regulation in 15 European countries: review [PDF]
, 2016 In the context of pharmaceutical care, policy-makers repeatedly face the challenge of balancing patient access to effective medicines with affordability and rising costs.
Arickx, Francis +23 more
core
Access in all areas? A round up of developments in market access and health technology assessment: part 2. [PDF]
J Comp Eff Res, 2023 Beattie A +3 more
europepmc +1 more source
Neuordnung der ambulanten Onkologie: Gutachten im Auftrag des Berufsverbandes der niedergelassenen Hämatologen und Onkologen e.V., der Deutschen Gesellschaft für Hämatologie und Onkologie e.V. und der Deutschen Krebsgesellschaft e.V. [PDF]
, 2012 Die Neuordnung der ambulanten spezialisierten fachärztlichen Versorgung steht auf der politischen Agenda. Gerade im Versorgungsbereich der Onkologie gibt es seit langem anhaltende Diskussionen über die vorherrschenden unterschiedlichen Betriebsformen ...
Farrenkopf, Nina +3 more
core
How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG? [PDF]
Appl Health Econ Health Policy, 2022 Dintsios CM, Chernyak N.
europepmc +1 more source